Comparison of Arthrogenic Muscle Inhibition (AMI) After ACL Reconstruction in Patients With Conventional Rehabilitation or Combined With DOCT'UP Digital Therapy

What this Trial Is About

Researchers are investigating the recovery process after anterior cruciate ligament (ACL) rupture, focusing on a condition called arthrogenic muscle inhibition (AMI). AMI reduces the ability of the quadriceps muscle to activate properly despite intact nerve and muscle structures, limiting recovery and rehabilitation after ACL injury. The study aims to assess whether adding a digital therapy tool to conventional rehabilitation can better address these neuromuscular deficits and improve patient outcomes. The trial compares two rehabilitation approaches following ACL reconstruction: conventional physiotherapy alone, which includes 40 supervised sessions, and augmented rehabilitation combining these physiotherapy sessions with the DOCT'UP digital therapy. DOCT'UP is a mobile application that supports patients with home-based exercises targeting AMI and general recovery. The digital therapy aims to enhance patient engagement and adherence alongside standard physical therapy. Participants will undergo scheduled physiotherapy sessions and use the mobile app as part of their rehabilitation. Researchers will monitor outcomes such as the rate of AMI at three weeks and adherence to physiotherapy over six months. Patients will be assessed for muscle function recovery, pain, and complications like Cyclops syndrome. The total participation includes follow-up assessments to evaluate the impact of the combined digital and conventional rehabilitation on recovery quality.

Comparison of Arthrogenic Muscle Inhibition (AMI) After ACL Reconstruction in Patients With Conventional Rehabilitation or Conventional Rehabilitation Combined With Digital Therapy